Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20126 | 475 | 40.7 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
103 | 3 | O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE | 73436 |
2562 | 2 | GALECTIN//GALECTIN 3//GALECTIN 1 | 3715 |
20126 | 1 | GROWTH DIFFERENTIATION FACTOR 15//GDF 15//GDF15 | 475 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GROWTH DIFFERENTIATION FACTOR 15 | authKW | 3017738 | 14% | 72% | 65 |
2 | GDF 15 | authKW | 2088254 | 10% | 69% | 47 |
3 | GDF15 | authKW | 1458421 | 7% | 69% | 33 |
4 | NAG 1 | authKW | 1235514 | 7% | 62% | 31 |
5 | MACROPHAGE INHIBITORY CYTOKINE 1 | authKW | 1090347 | 4% | 81% | 21 |
6 | MIC 1 | authKW | 828792 | 4% | 68% | 19 |
7 | GROWTH DIFFERENTIATION FACTOR 15 GDF15 | authKW | 267848 | 1% | 83% | 5 |
8 | MIC 1 GDF15 | authKW | 257136 | 1% | 100% | 4 |
9 | GROWTH AND DIFFERENTIATION FACTOR 15 | authKW | 192852 | 1% | 100% | 3 |
10 | MACROPHAGE INHIBITORY CYTOKINE 1 MIC 1 | authKW | 192852 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1163 | 27% | 0% | 127 |
2 | Cardiac & Cardiovascular System | 427 | 13% | 0% | 61 |
3 | Cell Biology | 260 | 14% | 0% | 65 |
4 | Medical Laboratory Technology | 245 | 4% | 0% | 19 |
5 | Endocrinology & Metabolism | 140 | 8% | 0% | 37 |
6 | Biochemistry & Molecular Biology | 84 | 15% | 0% | 73 |
7 | Peripheral Vascular Diseases | 75 | 4% | 0% | 21 |
8 | Medicine, Research & Experimental | 51 | 5% | 0% | 24 |
9 | Genetics & Heredity | 20 | 4% | 0% | 20 |
10 | Urology & Nephrology | 17 | 3% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ST VINCENTS PL MED | 143610 | 4% | 12% | 18 |
2 | MED TUMOR DETECT | 128568 | 0% | 100% | 2 |
3 | MOL TRANSLAT CARDIOL | 110773 | 2% | 19% | 9 |
4 | MOL RADIOBIOL BIODOSIMETRY | 85711 | 0% | 67% | 2 |
5 | MOL CARCINOGENESIS | 70521 | 8% | 3% | 39 |
6 | ANAT PHYS SCI RADIOL | 64284 | 0% | 100% | 1 |
7 | BIOMED OBES NUTR CIBEROBN | 64284 | 0% | 100% | 1 |
8 | CARDIOMETAB JKU | 64284 | 0% | 100% | 1 |
9 | COAGULAT INFLAMMAT SCI SCI LIFE | 64284 | 0% | 100% | 1 |
10 | DEVIS NEUROSURG | 64284 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE | 2961 | 1% | 2% | 3 |
2 | EUROPEAN JOURNAL OF HEART FAILURE | 972 | 1% | 0% | 6 |
3 | BIOMARKERS | 812 | 0% | 1% | 1 |
4 | CLINICAL CHEMISTRY | 768 | 3% | 0% | 12 |
5 | CANCER PREVENTION RESEARCH | 467 | 1% | 0% | 3 |
6 | CLINICAL CANCER RESEARCH | 417 | 2% | 0% | 10 |
7 | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY | 400 | 0% | 1% | 1 |
8 | CIRCULATION-CARDIOVASCULAR GENETICS | 396 | 0% | 0% | 2 |
9 | PROSTATE | 345 | 1% | 0% | 5 |
10 | CARCINOGENESIS | 341 | 2% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GROWTH DIFFERENTIATION FACTOR 15 | 3017738 | 14% | 72% | 65 | Search GROWTH+DIFFERENTIATION+FACTOR+15 | Search GROWTH+DIFFERENTIATION+FACTOR+15 |
2 | GDF 15 | 2088254 | 10% | 69% | 47 | Search GDF+15 | Search GDF+15 |
3 | GDF15 | 1458421 | 7% | 69% | 33 | Search GDF15 | Search GDF15 |
4 | NAG 1 | 1235514 | 7% | 62% | 31 | Search NAG+1 | Search NAG+1 |
5 | MACROPHAGE INHIBITORY CYTOKINE 1 | 1090347 | 4% | 81% | 21 | Search MACROPHAGE+INHIBITORY+CYTOKINE+1 | Search MACROPHAGE+INHIBITORY+CYTOKINE+1 |
6 | MIC 1 | 828792 | 4% | 68% | 19 | Search MIC+1 | Search MIC+1 |
7 | GROWTH DIFFERENTIATION FACTOR 15 GDF15 | 267848 | 1% | 83% | 5 | Search GROWTH+DIFFERENTIATION+FACTOR+15+GDF15 | Search GROWTH+DIFFERENTIATION+FACTOR+15+GDF15 |
8 | MIC 1 GDF15 | 257136 | 1% | 100% | 4 | Search MIC+1+GDF15 | Search MIC+1+GDF15 |
9 | GROWTH AND DIFFERENTIATION FACTOR 15 | 192852 | 1% | 100% | 3 | Search GROWTH+AND+DIFFERENTIATION+FACTOR+15 | Search GROWTH+AND+DIFFERENTIATION+FACTOR+15 |
10 | MACROPHAGE INHIBITORY CYTOKINE 1 MIC 1 | 192852 | 1% | 100% | 3 | Search MACROPHAGE+INHIBITORY+CYTOKINE+1+MIC+1 | Search MACROPHAGE+INHIBITORY+CYTOKINE+1+MIC+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | UNSICKER, K , SPITTAU, B , KRIEGLSTEIN, K , (2013) THE MULTIPLE FACETS OF THE TGF-BETA FAMILY CYTOKINE GROWTH/DIFFERENTIATION FACTOR-15/MACROPHAGE INHIBITORY CYTOKINE-1.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 24. ISSUE 4. P. 373-384 | 97 | 84% | 39 |
2 | BREIT, SN , JOHNEN, H , COOK, AD , TSAI, VWW , MOHAMMAD, MG , KUFFNER, T , ZHANG, HP , MARQUIS, CP , JIANG, LL , LOCKWOOD, G , ET AL (2011) THE TGF-BETA SUPERFAMILY CYTOKINE, MIC-1/GDF15: A PLEOTROPHIC CYTOKINE WITH ROLES IN INFLAMMATION, CANCER AND METABOLISM.GROWTH FACTORS. VOL. 29. ISSUE 5. P. 187 -195 | 74 | 80% | 63 |
3 | VANHARA, P , HAMPL, A , KOZUBIK, A , SOUCEK, K , (2012) GROWTH/DIFFERENTIATION FACTOR-15: PROSTATE CANCER SUPPRESSOR OR PROMOTER?.PROSTATE CANCER AND PROSTATIC DISEASES. VOL. 15. ISSUE 4. P. 320-328 | 79 | 80% | 16 |
4 | CORRE, J , HEBRAUD, B , BOURIN, P , (2013) CONCISE REVIEW: GROWTH DIFFERENTIATION FACTOR 15 IN PATHOLOGY: A CLINICAL ROLE?.STEM CELLS TRANSLATIONAL MEDICINE. VOL. 2. ISSUE 12. P. 946-952 | 62 | 87% | 22 |
5 | WANG, XY , BAEK, SJ , ELING, TE , (2013) THE DIVERSE ROLES OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG ACTIVATED GENE (NAG-1/GDF15) IN CANCER.BIOCHEMICAL PHARMACOLOGY. VOL. 85. ISSUE 5. P. 597-606 | 67 | 74% | 35 |
6 | XU, XY , LI, ZJ , GAO, W , (2011) GROWTH DIFFERENTIATION FACTOR 15 IN CARDIOVASCULAR DISEASES: FROM BENCH TO BEDSIDE.BIOMARKERS. VOL. 16. ISSUE 6. P. 466 -475 | 61 | 91% | 32 |
7 | ADELA, R , BANERJEE, SK , (2015) GDF-15 AS A TARGET AND BIOMARKER FOR DIABETES AND CARDIOVASCULAR DISEASES: A TRANSLATIONAL PROSPECTIVE.JOURNAL OF DIABETES RESEARCH. VOL. . ISSUE . P. - | 61 | 60% | 16 |
8 | MIMEAULT, M , BATRA, SK , (2010) DIVERGENT MOLECULAR MECHANISMS UNDERLYING THE PLEIOTROPIC FUNCTIONS OF MACROPHAGE INHIBITORY CYTOKINE-1 IN CANCER.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 224. ISSUE 3. P. 626-635 | 59 | 69% | 84 |
9 | TSAI, VWW , LIN, S , BROWN, DA , SALIS, A , BREIT, SN , (2016) ANOREXIA-CACHEXIA AND OBESITY TREATMENT MAY BE TWO SIDES OF THE SAME COIN: ROLE OF THE TGF-B SUPERFAMILY CYTOKINE MIC-1/GDF15.INTERNATIONAL JOURNAL OF OBESITY. VOL. 40. ISSUE 2. P. 193 -197 | 47 | 77% | 1 |
10 | HUSAINI, Y , QIU, MR , LOCKWOOD, GP , LUO, XW , SHANG, P , KUFFNER, T , TSAI, VWW , JIANG, LL , RUSSELL, PJ , BROWN, DA , ET AL (2012) MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1/GDF15) SLOWS CANCER DEVELOPMENT BUT INCREASES METASTASES IN TRAMP PROSTATE CANCER PRONE MICE.PLOS ONE. VOL. 7. ISSUE 8. P. - | 41 | 77% | 17 |
Classes with closest relation at Level 1 |